(Q30841807)

English

Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

0 references

0 references

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Naomi Rahimi-Levene

7

object named as

Naomi Rahimi-Levene

0 references

12

object named as

Aaron Polliack

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Tamar Tadmor

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Lev Shvidel

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Osnat Bairey

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Neta Goldschmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Rosa Ruchlemer

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Riva Fineman

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Naomi Rahimi-Levene

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yair Herishanu

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Mona Yuklea

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Ariela Arad

10

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Ariel Aviv

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Israeli CLL Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

2 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

E218-22

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Richter syndrome: biology, incidence, and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

How we treat Richter syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Geography, ethnicity and "roots" in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Richter syndrome and fludarabine: a controversial relationship.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Bendamustine in chronic lymphocytic leukemia and refractory lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Bcl-2 antagonists: a proof of concept for CLL therapy

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23826

21 January 2018

Identifiers

10.1002/AJH.23826

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30841807&oldid=2109062001"